English

Eligibility Leukemia NCT00899171

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00899171
Criteria
Description

Criteria

pretreatment rna specimens* available from patients with acute myeloid leukemia (aml) registered for front-line therapy on the following clinical trials:
Description

RNA Specimen pre treatment Available | Leukemia, Myelocytic, Acute | First line treatment Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0035668
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C2709094
UMLS CUI [1,4]
C0470187
UMLS CUI [2]
C0023467
UMLS CUI [3,1]
C1708063
UMLS CUI [3,2]
C0008976
swog-9031
Description

Clinical Trial Specified

Data type

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0205369
swog-9126
Description

Clinical Trial Specified

Data type

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0205369
swog-9333
Description

Clinical Trial Specified

Data type

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0205369
swog-9500
Description

Clinical Trial Specified

Data type

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0205369
cryopreserved pretreatment cell specimens* available from a subset of patients (those who obtained a complete response [cr] and remained in cr without relapse for ≥ 2 years vs those with resistant disease [i.e., failed to achieve cr with evidence of persistent aml following induction therapy]) note: all specimens currently available in the southwest oncology group myeloid leukemia and mds repository at the university of new mexico
Description

Cryopreserved Cell Specimen pre treatment Available | Patients In complete remission | Recurrent disease Absent | Patients Disease Resistant | Complete remission failed | AML persistent Post Induction Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1511548
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C2709094
UMLS CUI [1,4]
C0470187
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0677874
UMLS CUI [3,1]
C0277556
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0030705
UMLS CUI [4,2]
C0012634
UMLS CUI [4,3]
C0332325
UMLS CUI [5,1]
C0677874
UMLS CUI [5,2]
C0231175
UMLS CUI [6,1]
C0023467
UMLS CUI [6,2]
C0205322
UMLS CUI [6,3]
C0687676
UMLS CUI [6,4]
C0600558
patient characteristics:
Description

Client Characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
not specified
Description

Unspecified

Data type

boolean

Alias
UMLS CUI [1]
C0205370
prior concurrent therapy:
Description

Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C0087111
not specified
Description

Unspecified

Data type

boolean

Alias
UMLS CUI [1]
C0205370
Back to the top of the page

Similar models

Eligibility Leukemia NCT00899171

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00899171
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
RNA Specimen pre treatment Available | Leukemia, Myelocytic, Acute | First line treatment Clinical Trial
Item
pretreatment rna specimens* available from patients with acute myeloid leukemia (aml) registered for front-line therapy on the following clinical trials:
boolean
C0035668 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C2709094 (UMLS CUI [1,3])
C0470187 (UMLS CUI [1,4])
C0023467 (UMLS CUI [2])
C1708063 (UMLS CUI [3,1])
C0008976 (UMLS CUI [3,2])
Clinical Trial Specified
Item
swog-9031
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
Clinical Trial Specified
Item
swog-9126
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
Clinical Trial Specified
Item
swog-9333
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
Clinical Trial Specified
Item
swog-9500
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
Cryopreserved Cell Specimen pre treatment Available | Patients In complete remission | Recurrent disease Absent | Patients Disease Resistant | Complete remission failed | AML persistent Post Induction Therapy
Item
cryopreserved pretreatment cell specimens* available from a subset of patients (those who obtained a complete response [cr] and remained in cr without relapse for ≥ 2 years vs those with resistant disease [i.e., failed to achieve cr with evidence of persistent aml following induction therapy]) note: all specimens currently available in the southwest oncology group myeloid leukemia and mds repository at the university of new mexico
boolean
C1511548 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C2709094 (UMLS CUI [1,3])
C0470187 (UMLS CUI [1,4])
C0030705 (UMLS CUI [2,1])
C0677874 (UMLS CUI [2,2])
C0277556 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0030705 (UMLS CUI [4,1])
C0012634 (UMLS CUI [4,2])
C0332325 (UMLS CUI [4,3])
C0677874 (UMLS CUI [5,1])
C0231175 (UMLS CUI [5,2])
C0023467 (UMLS CUI [6,1])
C0205322 (UMLS CUI [6,2])
C0687676 (UMLS CUI [6,3])
C0600558 (UMLS CUI [6,4])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Back to the top of the page